Article
Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: common and specific effects of key regulators of fat-mass homoeostasis genes.
Pharmacogenetics and genomics - 1 Jul 2015
Creta Elia, Fabbri Chiara, Serretti Alessandro
Abstract excerpt
OBJECTIVE: Second-generation antipsychotics (SGAP) and mood stabilizers (MS) are prescribed widely for the treatment of bipolar disorder, but they are associated with the risk of relevant side-effects, among which is weight gain. The identification of genes that predispose to weight gain would represent a useful tool to evaluate the risk-benefit ratio of treatment. MATERIALS AND METHODS: This study investigated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
